Business Description
Greenyn Biotechnology Co Ltd
ISIN : TW0006846009
Total Employee Number:
126Description
Greenyn Biotechnology Co Ltd is engaged in the business of health food raw materials production and sales of raw materials and production and sales of formula preparation.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.26 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.94 | |||||
Debt-to-EBITDA | 3.94 | |||||
Interest Coverage | 15.77 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.67 | |||||
Beneish M-Score | -3 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2 | |||||
3-Year EBITDA Growth Rate | -7.2 | |||||
3-Year EPS without NRI Growth Rate | -8.4 | |||||
3-Year Book Growth Rate | 16.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.82 | |||||
9-Day RSI | 40.51 | |||||
14-Day RSI | 41.02 | |||||
3-1 Month Momentum % | -5.34 | |||||
6-1 Month Momentum % | -9.3 | |||||
12-1 Month Momentum % | -11.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.84 | |||||
Quick Ratio | 6.02 | |||||
Cash Ratio | 5.31 | |||||
Days Inventory | 123.41 | |||||
Days Sales Outstanding | 41.84 | |||||
Days Payable | 54.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.22 | |||||
Dividend Payout Ratio | 0.77 | |||||
3-Year Dividend Growth Rate | 0.5 | |||||
Forward Dividend Yield % | 6.22 | |||||
5-Year Yield-on-Cost % | 6.24 | |||||
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | -33.72 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.08 | |||||
Operating Margin % | 20.63 | |||||
Net Margin % | 15.9 | |||||
EBITDA Margin % | 25.39 | |||||
FCF Margin % | -25.8 | |||||
OCF Margin % | 17.36 | |||||
ROE % | 16.07 | |||||
ROA % | 8.1 | |||||
ROIC % | 24.82 | |||||
3-Year ROIIC % | 3.38 | |||||
ROC (Joel Greenblatt) % | 39.61 | |||||
ROCE % | 12.57 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.51 | |||||
Forward PE Ratio | 12.89 | |||||
PE Ratio without NRI | 13.5 | |||||
Price-to-Owner-Earnings | 72.56 | |||||
PS Ratio | 2.25 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 1.76 | |||||
Price-to-Operating-Cash-Flow | 13 | |||||
EV-to-EBIT | 7.51 | |||||
EV-to-EBITDA | 6.36 | |||||
EV-to-Revenue | 1.62 | |||||
EV-to-FCF | -6.66 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Graham-Number | 1.03 | |||||
| Price-to-Net-Current-Asset-Value | 4.84 | |||||
| Price-to-Net-Cash | 75.48 | |||||
Earnings Yield (Greenblatt) % | 13.32 | |||||
FCF Yield % | -13.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Greenyn Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 915.321 | ||
| EPS (TTM) (NT$) | 4.69 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.85 | ||
| 3-Year Sortino Ratio | -1.02 | ||
| Volatility % | 11.98 | ||
| 14-Day RSI | 41.02 | ||
| 14-Day ATR (NT$) | 1.95454 | ||
| 20-Day SMA (NT$) | 64.91 | ||
| 12-1 Month Momentum % | -11.45 | ||
| 52-Week Range (NT$) | 62 - 78.2 | ||
| Shares Outstanding (Mil) | 27.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Greenyn Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Greenyn Biotechnology Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 3.944481 Cash Dividend | 2026-06-25 | 67.00 (+1.36%) | ||
| TWD 3.598666 Cash Dividend | 2025-03-26 | 85.40 (-1.61%) |
Show
Entries
Greenyn Biotechnology Co Ltd Frequently Asked Questions
What is Greenyn Biotechnology Co Ltd(ROCO:6846)'s stock price today?
The current price of ROCO:6846 is NT$63.40. The 52 week high of ROCO:6846 is NT$78.20 and 52 week low is NT$62.00.
When is next earnings date of Greenyn Biotechnology Co Ltd(ROCO:6846)?
The next earnings date of Greenyn Biotechnology Co Ltd(ROCO:6846) is .
Does Greenyn Biotechnology Co Ltd(ROCO:6846) pay dividends? If so, how much?
The Dividend Yield %  of Greenyn Biotechnology Co Ltd(ROCO:6846) is 6.22% (As of Today), Highest Dividend Payout Ratio of Greenyn Biotechnology Co Ltd(ROCO:6846) was 0.79. The lowest was 0.6. And the median was 0.72. The  Forward Dividend Yield % of Greenyn Biotechnology Co Ltd(ROCO:6846) is 6.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Greenyn Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers